Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Change in Cash (2019 - 2026)

Enliven Therapeutics has reported Change in Cash over the past 8 years, most recently at $33.3 million for Q1 2026.

  • Quarterly results put Change in Cash at $33.3 million for Q1 2026, up 248.17% from a year ago — trailing twelve months through Mar 2026 was $30.5 million (up 164.15% YoY), and the annual figure for FY2025 was -$25.3 million, down 205.42%.
  • Change in Cash reached $33.3 million in Q1 2026 per ELVN's latest filing, up from -$2.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $216.6 million in Q1 2023 and bottomed at -$166.4 million in Q2 2023.
  • Median Change in Cash over the past 5 years was -$6.3 million (2022), compared with a mean of $1.3 million.
  • Peak annual rise in Change in Cash hit 2234.5% in 2023, while the deepest fall reached 2141.81% in 2023.
  • Over 5 years, Change in Cash stood at -$10.6 million in 2022, then surged by 347.52% to $26.3 million in 2023, then fell by 10.64% to $23.5 million in 2024, then tumbled by 112.07% to -$2.8 million in 2025, then soared by 1273.77% to $33.3 million in 2026.
  • Business Quant data shows Change in Cash for ELVN at $33.3 million in Q1 2026, -$2.8 million in Q4 2025, and -$17.7 million in Q3 2025.